Showing results (31-40 of 166) with videos related to
Sort By:
Pageof 17
Molecular Pharmacology|September 22, 2000
RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium releaseR D Price, E Sanders-BushEuropean Journal of Pharmacology|September 1, 1975
Synaptosomal uptake and levels of serotonin in rat brain areas after p-chloroamphetamine or B-9 lesionsV J Massari, E Sanders-BushMolecular Pharmacology|November 1, 1994
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonistsR S Westphal, E Sanders-BushMolecular Pharmacology|March 1, 1996
Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell divisionR S Westphal, E Sanders-BushBrain Research|April 24, 1995
Developmental switch in the hippocampal serotonin receptor linked to phosphoinositide hydrolysisJ Ike, H Canton, E Sanders-BushEuropean Journal of Pharmacology|January 13, 1987
5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drugE Sanders-Bush, M Breeding, M RoznoskiThe Journal of Biological Chemistry|June 5, 1989
Transferrin gene expression and synthesis by cultured choroid plexus epithelial cells. Regulation by serotonin and cyclic adenosine 3',5'-monophosphateM Tsutsumi, M K Skinner, E Sanders-BushThe Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblastsM S Grotewiel, H Chu, E Sanders-BushThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1975
Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanismsE Sanders-Bush, J A Bushing, F SulserNIDA Research Monograph|January 1, 1992
Hallucinogens and serotonergic mechanismsR A Glennon, M Teitler, E Sanders-BushPageof 17